Study offers a potential strategy to improve T cell therapy in solid tumors
byPerelman School of Medicine at the University of PennsylvaniaRegnase-1 and Roquin-1 double knockout alters the activation profile of resting engineered T cells. (A) Healthy human donor T cells
Updated on: December 22,2023
9

Study offers a potential strategy to improve T cell therapy in solid tumors
byPerelman School of Medicine at the University of PennsylvaniaRegnase-1 and Roquin-1 double knockout alters the activation profile of resting engineered T cells. (A) Healthy human donor T cells
Updated on:December 22,2023
9
